RAPT Therapeutics, Inc.
RAPTDrugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Apr 2027
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in RAPT Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in RAPT Therapeutics, Inc.'s (RAPT) pipeline across Phase 2. Its lead program is FLX475 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is RAPT Therapeutics, Inc.'s next FDA catalyst?→
RAPT Therapeutics, Inc.'s (RAPT) next tracked catalyst is a Phase 2 expected April 15, 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track RAPT biotech catalysts?→
Add RAPT to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow RAPT Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.